Clinical Trial

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated November 15, 2024 completion). Its status may not reflect the trial's current state.
Summary
The investigators hypothesized that in terms of granulocyte colony-stimulating factor (G-CSF) administration, the route of continuous infusion would lead to a faster neutrophil recovery compared to that of bolus administration
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-11-21; most recent amendment 2024-09-11.
Status change: Recruiting → Active, Not Recruiting 2024-09-11
Trial Details
NCT Number NCT06145321
Lead Sponsor Chang Gung Memorial Hospital
Conditions Pediatric Cancer, Neutropenia, Lenograstim, Filgrastim, G-CSF
Enrollment 20 participants
Start Date 2023-11-23
Primary Completion 2024-11-15 (estimated)
Study Completion 2024-11-15 (estimated)
Updated on ClinicalTrials.gov 2024-09-19